{"name":"Frequency Therapeutics","slug":"frequency-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":6392000,"revenueGrowth":181.5,"grossMargin":0,"rdSpend":65575000,"netIncome":-117260000,"cash":113506000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-03-12","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNVWRKd1J1VFNGVjVDc20yekY2ZVF5cDdrYlJHWktfV19qZDlHcjBoNkhoMnVoYWY5YzlELWh6LTBGNXA2R0FQM1Jrc0QxTndwX1hKTHNHajZfbjNGLUJQamhxcFNhUEZ0S3hpdF82UTJmT2ZoWkczSWlYM1o5NVRlNUpKTWdURVVUSFNfR2JEUk9mVnBxQ19xWGt3bTVEQ1dKcTZzck9IanZxUQ?oc=5","date":"2025-10-31","type":"trial","source":"endpoints.news","summary":"OrbiMed-backed biotech quickly changes CEOs; Adaptimmune co-founder to lead Evaxion - endpoints.news","headline":"OrbiMed-backed biotech quickly changes CEOs; Adaptimmune co-founder to lead Evaxion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQMVhCdndlQmoxQ1Nxa3ZLekZpenptOTVUTFdLZFRWOEZwbGxsVHRHZEJqUlBlV2JSYjFkUEFIVjhHTkFMejBVdDY3VUpValJGQ1RwZFJQVmJPaWVXa3VJZkVMY1JCQ2tXVklOZC1jcHl6dnpsSDhIRGNvSlhvcHRyeVdQYw?oc=5","date":"2025-07-17","type":"pipeline","source":"Medical Device Network","summary":"Astellas Pharma and Frequency Therapeutics collaborate on hearing loss therapy - Medical Device Network","headline":"Astellas Pharma and Frequency Therapeutics collaborate on hearing loss therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQSzloeml6bTh2akJsUTUzWmpwb2JVMGpkUzBoYjdtOXRsNDhxdnVYMUxGM3lrZTR6TDFpN2NBbFROelNBQk1aWXcwMTVoWmJUTEtYVGFJdHVwakd1cnRzX3oxekh5MjZzU1pfVXFrekFLV0RNLWxVNFFpbWxNa1d3dEoxT0ZKbm5UN3VlVkdCS2k4dGpBcHpGWmVudkY?oc=5","date":"2024-08-13","type":"pipeline","source":"Yahoo Finance","summary":"Astellas Pharma and Frequency Therapeutics collaborate on hearing loss therapy - Yahoo Finance","headline":"Astellas Pharma and Frequency Therapeutics collaborate on hearing loss therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQVEFrb3dya0FFYWZwOTVBaV81OGtkMkpaNHU1XzdRRmVXNWZWX1VjTzcyMFdWcFlJYm9uOVZsak1LUk12U2ZJMDcwZk5uOWItdVJWQ3lhMUhFLXdjbHhOaFhqVWdZaUdfLUtuU1VCT0pFY1hHd2ZiZXc1dmROSmlDMXB0cGRvUWRoejZDSjBVSXVCWF9vN0cyeXZMejgtZldkTWExbW5aaDQ?oc=5","date":"2024-07-02","type":"pipeline","source":"Bloomberg Law News","summary":"Frequency Therapeutics Defeats Investor Claims Over Hearing Drug - Bloomberg Law News","headline":"Frequency Therapeutics Defeats Investor Claims Over Hearing Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNTnlSODhwdHh3SU9wZkNKWlRzLXZyQjkxbDgzU2hqY1dFSWtQVC0ydXF3UlZRVjRwelJpRU5kXzVoTUJhei1mYU1RSjQ3QW5lbHJQQ1U4RWdscUFSM2lINkRMMzR3eGJsZGpBbGN0SU8wZ3hBRW9DLVYxNTR3dzBVVmVtSQ?oc=5","date":"2023-07-18","type":"pipeline","source":"labiotech.eu","summary":"Korro Bio and Frequency Therapeutics to merge - labiotech.eu","headline":"Korro Bio and Frequency Therapeutics to merge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOdFVwdEl2d29oaVBOYjZxdk5rd1M2QVg0cm9jcDIxelN2YVR2RWdNeE1Weks1dnZJY0tmbmxfbmg3QlBNamllVVY0T2dSazVQSTFESmtLdF9laUEwWklOSWJxSFNES2wwRmtwV2l5M3hDUlRXU09xTy00WWZXeVpmeDREZ3lxbVJNbU1wdzBaZEhZRkI0c3RYNFZLZl9RamZFZUlaZFdHSQ?oc=5","date":"2023-02-13","type":"trial","source":"drugdiscoverytrends.com","summary":"Frequency Therapeutics shares plummet after FX-322 Phase 2b failure - drugdiscoverytrends.com","headline":"Frequency Therapeutics shares plummet after FX-322 Phase 2b failure","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNbURNNUxqZ2JmRnRBQ0dTMEFNbTdIWHNWdXlBTlpuODNrWG9jbkZIQ2tOLXpJWHhBX211emd6MFZhTEprQWdaekNmMlBWOGxOaFUxU2R3ellLNnptcm1lZ3FtTDF0QTBrbXNzajBKblZCUzU2NnlkVWlUUnEzMVdpcE5tY2VlOWc3R191cXM0eWlncEpRZEtMZEtn?oc=5","date":"2023-02-13","type":"trial","source":"BioPharma Dive","summary":"Frequency to cut jobs after clinical trial setback - BioPharma Dive","headline":"Frequency to cut jobs after clinical trial setback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQLW5Bb3RrZ0tidWdwX1k4cUVnSXEwOEQwVHdkVWR6LWp0VFpfRWVTVEVOSEtDSXJobk1sbmp1TFU0WWx0TmNkeDJIcXBneENjV3gxTjVQMEZYZXFPd3NfbGt3TTlRNGZ5MDgwdVZzNUxWYmo3RDFWV09US0lualZGOUFsSWNhNlZNSnJRWU5YQWRFUGhCOUdiMkZQUnFZSGpRdU5idWZrMG92Ymo5UVFlUkV2dTFWUQ?oc=5","date":"2021-03-17","type":"trial","source":"Drug Delivery Business","summary":"Frequency Therapeutics drug shows promise in restoring hearing in small study - Drug Delivery Business","headline":"Frequency Therapeutics drug shows promise in restoring hearing in small study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQdEdCTDlSWU95WjBrbkZTZUJoMXQ1QnNiN3J1SWF4MVBEejdVX3RYVEt5UEFhUmwwRVhNcVFMcGpDcVMwOV9SdXQ5c1gwcUU4N3AxOVJsdWhrWUxfQWVEMEItU3FIYTJndVRuUklHeGx1YmZ6eF9pMFpfenByN0hockVDdlZ6OUNqcm1oR19R?oc=5","date":"2019-07-23","type":"pipeline","source":"statnews.com","summary":"Frequency Therapeutics raises another $62 million - statnews.com","headline":"Frequency Therapeutics raises another $62 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNNElDLUxWOXh4VTVJd2tTaC1reGdTNGx1dWJkMWtHcjl2SjNneFlNVEdqbG8tenBSeFA1aUtmZXhxVVhBd1dvZXVlQklDbXVNelFxeFVMdFkxdm1YY2NBYkhoODRuZ1RXRkx4X3djMzEzczE3WmNPeWRWcGF4MWZDVFJPZy0xSXpYQVc3Skx1RVBxcms?oc=5","date":"2019-07-18","type":"pipeline","source":"Pharmaceutical Technology","summary":"Astellas licences Frequency Therapeutics’ hearing loss drug - Pharmaceutical Technology","headline":"Astellas licences Frequency Therapeutics’ hearing loss drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPelFVaVJLYWVib3gyLU1Gc0lta3dwLUZhNzVhUjJsdjE1dnJ4R0JPZHZOeFh4MUt2ZkNJSnJkUGxlTV9ySTFaSVI3c3hBNWkwTkt1M0wzTzZHLWtMYkNLUnh6WFB0U3B5UVphcnBxVG9oRm55OWdNSnd3N2dSNW9DOGdPNXVtTDVRMy16WkV1SWRYXzE3aTVNXzRNTnJlWlM1TU0welBVYUdwa2VzN0NhZW5iVEdFTjEzUHdsbU5fTVhHV1Na?oc=5","date":"2019-07-18","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Astellas, Frequency Therapeutics Partner to Develop Hearing Loss Drug - Genetic Engineering and Biotechnology News","headline":"Astellas, Frequency Therapeutics Partner to Develop Hearing Loss Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNS2N0U1RGUVRpaTdMX2JEYXllY3lnekxSekh4YjViOWZLSXVrcE4ycUhLWHpmZFh4b0pvY3NkWVY4djd3R2JGcHM5WXhKQ3M4ZU13U3hoNS1tSXY2dFVvR29GaEVLSzVFU2RTZG5PcjQ5YUpwd3BMeGdiQ09wdm5nOVhKaTRZSTRYU3pKZF83ZFI4a1FRVWFna1U1N3ZmMzcwZHZxNWxWTzhqQUVMVklGT0lrR2lJaXBV?oc=5","date":"2019-07-17","type":"pipeline","source":"Fierce Biotech","summary":"Astellas picks up Frequency's regenerative hearing loss med outside U.S. for $80M - Fierce Biotech","headline":"Astellas picks up Frequency's regenerative hearing loss med outside U.S. for $80M","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":6392000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":6392000,"period":"2025-12-31"},{"value":2271000,"period":"2024-12-31"},{"value":2271000,"period":"2024-12-31"},{"value":0,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":65575000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-117260000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":113506000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}